(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)地区经理 |
Urumqi (Xinjiang Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)地区经理 |
Urumqi (Xinjiang Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)地区经理 |
Urumqi (Xinjiang Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)地区经理 |
Urumqi (Xinjiang Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xuzhou (Jiangsu Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Taian (Shandong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)地区经理 |
Urumqi (Xinjiang Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
(高级)地区经理 |
Urumqi (Xinjiang Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 31, 2024 |
Record to Report Sr Specialist TDSA |
INSURGENTES |
Mexiko |
Finance |
CTS |
Audit und Finanzen |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Nantong (Jiangsu Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Nantong (Jiangsu Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
Hire to Retire Services Expert |
Selangor |
Malaysia |
People & Organization |
CTS |
Humanressourcen |
Okt. 30, 2024 |
Site Engineering Head / Directeur Ingénierie et Maintenance (m/f/d) |
Huningue |
Frankreich |
Operations |
Innovative Medicines |
Technical Operations |
Okt. 30, 2024 |
H2R Services Expert |
Hyderabad (Office) |
Indien |
People & Organization |
CTS |
Humanressourcen |
Okt. 30, 2024 |
Global GMP Senior Quality Auditor |
Barcelona Provincial |
Spanien |
Operations |
Innovative Medicines |
Quality |
Okt. 30, 2024 |
Field Project Manager |
Amsterdam |
Niederlande |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
Procurement S2C Process Excellence Lead |
Prague |
Tschechische Republik |
Operations |
CTS |
Beschaffung |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
Associate Director Analytical Operations / Head External Analytical Organization (f/m/d) |
Schaftenau |
Österreich |
Development |
Innovative Medicines |
Research & Development |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
SCM Expert |
Indianapolis |
USA |
Operations |
Innovative Medicines |
Technical Operations |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Nantong (Jiangsu Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
Okt. 30, 2024 |
Medical Science Liaison, Hematology |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Okt. 30, 2024 |